Search DubaiPRNetwork.com

Home >> Banking & Investments

Dubai Investments acquires stake in Globalpharma for 100% ownership

Thursday, February 7, 2019/ Editor -  

Share

Home >> Banking & Investments

Dubai, February 7, 2019: Dubai Investments PJSC [DFM: DIC], the diversified leading company listed on the Dubai Financial Market, today announced the acquisition of an additional 66% stake in Globalpharma. Following the acquisition, made through Dubai Investments Industries, the pharmaceuticals company will now be a wholly owned subsidiary of Dubai Investments.

In 2014, Dubai Investments divested a 66% stake and had continued to hold a minority 34% equity in the subsidiary.
  
Khalid Bin Kalban, Managing Director and CEO of Dubai Investments PJSC, said: “Our original investment in Globalpharma was well timed and good for the growth of the healthcare sector in the UAE and region. We see the strategic benefit for making this acquisition. It forms part of the Dubai Investments growth strategy, and underscores our commitment to creating more value for our shareholders. 

“Our healthcare portfolio includes different stakes in KCH Healthcare LLC, Clemenceau Medical Centre, tie ups with hospital operators such as NMC in Dubai Investments Park and Mirdif Hills. These investments not only achieve key business objectives for Dubai Investments and support the Dubai economy, they also contribute to the wellbeing of the UAE, improve the reputation of Dubai as a hub for world-class medical care and align with the long term plans of the UAE government for sustainability and progress in fields such as health and science.”

Established in 1998 and headquartered in Dubai Investments Park, Globalpharma grew to become a market leader in certain generic medicines with a strong regional footprint. Globalpharma manufactures and markets pharmaceutical products in more than 14 countries across the GCC, Middle East and neighbouring markets.

Globalpharma manufactures and commercializes pharmaceutical products under CGMP (current good manufacturing practice) conditions including antibiotics, cardiovascular, anti-ulcerants, analgesic, NSAIDs (Nonsteroidal anti-inflammatory drugs), food supplements, vitamins, anti-diabetics, respiratory products and anti-histamine formulations. 


Previous in Banking & Investments

Next in Banking & Investments


Home >> Banking & Investments Section

Latest Press Release

Year of Tolerance logo inspires ADU's new Al Ain campus design

The Dubliners St. Patrick's Day

‘Take Water. Give Life'

Ireland Claims CSI2* Longines Grand Prix Win on Day 3 of President's Cup

Get closer- your makeup is invisible with Make Up For Ever's New Ultra HD Concea ...

Research finds increased sulfur metabolism is a likely survival mechanism for na ...

Pakistan International Airlines launches bi-weekly flights to Al Ain Internation ...

Galaxy S10 series now available for pre-order in the UAE

Modest Fashion Week Returns to Dubai for 2019

Three New Breitling Watches Commemorate an Aviation Legend: The Curtiss P-40 Wa ...

The Emirates A380 to take centre stage at the Saudi International Airshow

Dubai Customs ties strategy to the 8 principles of governance

Super Six as Pogacar picks up top spot in Portugal

Ibn Battuta Mall hosts Pink Caravan clinic to raise awareness about breast cance ...

Ras Al Khaimah Ruler to present inaugural Sheikh Saud bin Saqr Al Qasimi Interna ...

Splash launches Adaptive Collection for People of Determination

Key Trends of Spring/Summer 2019 and How to Wear Them

Lucky Number Five for UAE In FEI Longines Jumping Nations Cup™ Draw

Procter & Gamble Announces Newest Commitment to Gender Equality Across the India ...

The Beard Gear Company